Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso
about
Incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt: a systematic review and meta-analysisAmbiguous Capture: Collaborative Capitalism and the Meningitis Vaccine ProjectEmergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.Serogroup-Specific Characteristics of Localized Meningococcal Meningitis Epidemics in Niger 2002-2012 and 2015: Analysis of Health Center Level Surveillance DataMeningococci of Serogroup X Clonal Complex 181 in Refugee Camps, Italy.Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study.Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008Determination of pneumococcal serotypes in meningitis cases in Niger, 2003-2011Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity.Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, NigerAnalysis of the bactericidal response to an experimental Neisseria meningitidis vesicle vaccineTemporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia.An outbreak of pneumococcal meningitis among older children (≥5 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana.Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccineRandomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlersMobile microbiological laboratory support for evaluation of a meningitis epidemic in Northern Benin.Rise of the microbes.Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.Neisseria meningitidis serogroup W, Burkina Faso, 2012.Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.Can we, should we, eradicate the meningococcus?Glycoconjugate vaccines.Meningococcal disease: changes in epidemiology and prevention.Meningococcal vaccines: current issues and future strategies.Evolving meningococcal immunization strategies.Glycoconjugate vaccines: an update.Evaluation of response strategies against epidemics due to Neisseria meningitidis C in Niger.Synthesis and immunological evaluation of protein conjugates of Neisseria meningitidis X capsular polysaccharide fragments.Effect of a vaccine to prevent serogroup A N meningitidis epidemics in Africa.The development of an experimental multiple serogroups vaccine for Neisseria meningitidis.Conjugate vaccine introduction in the African meningitis belt: meeting surveillance objectives.Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia.[Impact of a conjugated anti meningococcal A vaccine on notification of bacterial meningitis in West Burkina Faso (2009-2012)].Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal disease.An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt.Vaccine Prevention of Meningococcal Disease in Africa: Major Advances, Remaining Challenges.An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidate.
P2860
Q26825352-38926EC6-E4D7-4F86-B6AD-36A4734FAA47Q28598111-6ADD6F83-33D8-40E9-A2A6-C048581038C6Q31124227-DF1050C2-2AF1-47E5-A27F-258716E8A3EEQ31132449-5F12E6D0-ED97-4703-8DBD-E7124EA08FA2Q33597067-955089BD-2A44-4DBF-A2BF-16932598D531Q34119532-19005E2F-1144-4B25-A05C-161C44D2D4E0Q34346578-A78FB6D2-8E28-4347-8B2A-63C1D5A76D33Q34430626-E29FE749-C238-456C-818D-3554DCAD8CC1Q34606343-FECD1D53-6345-48E6-BD2C-127A497CCFB2Q34653891-4E097E70-0037-4FE1-8482-300D507124CAQ34892719-FEADB0E0-9A35-4A52-9140-5AAC73731C6FQ35639159-7B01AD8A-C1F2-4CF0-B872-CE6AD8A4BCE1Q35897046-98E5A01C-A133-4DD7-A3FF-3310690150B2Q35940761-A21B7159-0074-4B6B-9D24-3F79EF5BAC94Q36064003-D201654D-A500-4F2F-8034-923AA385643BQ36166629-6FC38159-9827-4711-A91F-F4223D970D28Q36183088-A03B5F31-2977-4BFF-8A4D-2CDF207DE82CQ36849834-D7699D39-4898-4F3C-A644-7ECBD3263CD1Q36976418-3AA8619C-5F5D-44D9-A43F-68128247D1A4Q37014766-7CAB6A52-4AED-4F77-AA32-8DC4E7A97921Q37340824-C2A546D8-08D2-4075-85D7-0C6F0C670469Q37621672-448403A3-0D34-4DB8-80A0-F698CC441770Q37956384-E1B76AFF-11AF-41AC-92D8-0406F1C8D1A1Q38011316-0B61CEBA-9874-4AA7-97B5-3FAF4CA3260FQ38044755-02EFDDCA-F202-4A10-8A5D-F366521A7ED6Q38052545-21464E2D-0125-468E-A290-5B0A6F5AA817Q38120493-0623CC32-21C0-4704-A19B-2ADE711035CCQ38286082-AB647F1B-BA62-4584-8727-A8A87C071CD8Q38286346-28F7239C-938E-4D99-8E05-64D7DF23A748Q40469813-4E802870-8D59-47D2-B7AD-E713C16ED69AQ41669855-11792CDA-4072-47E6-BD30-AA1D6CADBD8EQ42025169-EA7E67DE-8991-4484-83B6-A8E1FE60396BQ42131377-73269394-5C8B-4D1E-8E92-17ABD9BC2D77Q42287903-487FBE6A-847D-4D93-8C96-BA453C44A75FQ43083529-281FEE10-4077-4AB6-810E-75E262BEF877Q43927963-FDD6BCA5-EB23-4608-8E06-CC30DC7213A1Q46027898-3A1A14F1-257A-4ADF-9BF4-4C8D1DCD6363Q46265378-2D9AA089-F818-4317-97FE-8E886C86657DQ46535546-7A5D3825-0D1F-4D9E-85A4-7A4E756F25BAQ47170219-EDF2BF9A-7BA5-4920-BFAD-C17C71C40159
P2860
Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Emergence of epidemic Neisseri ...... gitis in Togo and Burkina Faso
@ast
Emergence of epidemic Neisseri ...... gitis in Togo and Burkina Faso
@en
Emergence of epidemic Neisseri ...... gitis in Togo and Burkina Faso
@nl
type
label
Emergence of epidemic Neisseri ...... gitis in Togo and Burkina Faso
@ast
Emergence of epidemic Neisseri ...... gitis in Togo and Burkina Faso
@en
Emergence of epidemic Neisseri ...... gitis in Togo and Burkina Faso
@nl
prefLabel
Emergence of epidemic Neisseri ...... gitis in Togo and Burkina Faso
@ast
Emergence of epidemic Neisseri ...... gitis in Togo and Burkina Faso
@en
Emergence of epidemic Neisseri ...... gitis in Togo and Burkina Faso
@nl
P2093
P2860
P921
P3181
P1433
P1476
Emergence of epidemic Neisseri ...... gitis in Togo and Burkina Faso
@en
P2093
Berthe-Marie Njanpop-Lafourcade
Bradford D Gessner
Haoua Tall
Isabelle Delrieu
Jean L Kambou
Judith E Mueller
Kossi Badziklou
Macaire S Ouedraogo
Oumarou Sanou
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0019513
P407
P577
2011-01-01T00:00:00Z